Loading…
Lobbying Spend
—
Filings
55
Firms Hired
2
Active Period
2013–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Advocacy related to Bladder cancer treatment and blue light cystoscopy, H.R. 8032.
Client expense: — · Firm income: $70,000
Matched citations: H.R. 8032
Advocacy related to Bladder cancer treatment and blue light cystoscopy, H.R. 8032.
Client expense: — · Firm income: $70,000
Matched citations: H.R. 8032
Advocacy related to Bladder cancer treatment and blue light cystoscopy, H.R. 8032.
Client expense: — · Firm income: $70,000
Matched citations: H.R. 8032
Ensuring Equal Access to Treatments Act of 2015
2016 · fourth_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $27,000
Matched citations: H.R. 1178
Ensuring Equal Access to Treatments Act of 2015
2016 · fourth_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $27,000
Matched citations: S. 1466
Ensuring Equal Access to Treatments Act of 2015
2016 · third_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1178
Ensuring Equal Access to Treatments Act of 2015
2016 · third_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $30,000
Matched citations: S. 1466
Ensuring Equal Access to Treatments Act of 2015
2016 · second_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1178
Ensuring Equal Access to Treatments Act of 2015
2016 · second_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: S. 1466
Ensuring Equal Access to Treatments Act of 2015
2016 · first_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1178
Ensuring Equal Access to Treatments Act of 2015
2016 · first_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: S. 1466
Ensuring Equal Access to Treatments Act of 2015
2015 · third_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1178
Ensuring Equal Access to Treatments Act of 2015
2015 · third_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: S. 1466
Ensuring Equal Access to Treatments Act of 2015
2015 · fourth_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1178
Ensuring Equal Access to Treatments Act of 2015
2015 · fourth_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: S. 1466
Ensuring Equal Access to Treatments Act of 2015
2015 · third_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1178
Ensuring Equal Access to Treatments Act of 2015
2015 · third_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: S. 1466
Ensuring Equal Access to Treatments Act of 2015
2015 · second_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1178
Ensuring Equal Access to Treatments Act of 2015
2015 · second_quarter · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $50,000
Matched citations: S. 1466
Ensuring Equal Access to Treatments Act of 2015
2015 · first_quarter · Firm: KING & SPALDING LLP
Support of HR 1178, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Client expense: — · Firm income: $70,000
Matched citations: HR 1178
Ensuring Equal Access to Treatments Act of 2014
2014 · fourth_quarter · Firm: KING & SPALDING LLP
Advocacy in support of Medicare coverage for outpatient cancer drugs, including H.R. 4857, Ensuring Equal Access to Treatments Act of 2014
Client expense: — · Firm income: $90,000
Matched citations: H.R. 4857
Ensuring Equal Access to Treatments Act of 2014
2014 · third_quarter · Firm: KING & SPALDING LLP
Advocacy in support of Medicare coverage for outpatient cancer drugs, including H.R. 4857, Ensuring Equal Access to Treatments Act of 2014
Client expense: — · Firm income: $80,000
Matched citations: H.R. 4857
Ensuring Equal Access to Treatments Act of 2014
2014 · second_quarter · Firm: KING & SPALDING LLP
Advocacy in support of Medicare coverage for outpatient cancer drugs, including H.R. 4857, Ensuring Equal Access to Treatments Act of 2014
Client expense: — · Firm income: $80,000
Matched citations: H.R. 4857
Source: Senate LDA